Location History:
- Otsu, JP (2016)
- Minamishimabara, JP (2021)
Company Filing History:
Years Active: 2016-2021
Title: Takehiro Sagara: Innovator in Nucleic Acid Technologies
Introduction
Takehiro Sagara is a prominent inventor based in Minamishimabara, Japan. He has made significant contributions to the field of molecular biology, particularly in the development of novel methods and enzymes for nucleic acid manipulation. With a total of 2 patents, Sagara's work has the potential to advance various applications in genetic research and diagnostics.
Latest Patents
Sagara's latest patents include innovative methods utilizing thermostable mismatch endonuclease. This polypeptide recognizes and cleaves mismatches in nucleic acids, providing a method for removing errors in nucleic acid amplification reactions. Additionally, he has developed techniques for inhibiting the amplification of specific nucleotide sequences and for detecting nucleic acids with single-nucleotide polymorphism mutations. Another significant patent involves the provision of various novel DNA polymerases, including a modified DNA polymerase with an amino acid sequence alteration that enhances its functionality.
Career Highlights
Throughout his career, Takehiro Sagara has worked with esteemed institutions such as Kyushu University and Takara Bio Inc. His research has focused on improving the accuracy and efficiency of nucleic acid amplification and manipulation techniques, which are crucial for various applications in biotechnology and medicine.
Collaborations
Sagara has collaborated with notable colleagues in his field, including Yoshizumi Ishino and Takeshi Yamagami. These collaborations have contributed to the advancement of research in nucleic acid technologies and have fostered innovation in the scientific community.
Conclusion
Takehiro Sagara's contributions to the field of molecular biology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in genetic research and diagnostics.